HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Target Identification of the Marine Natural Products Dictyoceratin-A and -C as Selective Growth Inhibitors in Cancer Cells Adapted to Hypoxic Environments.

Abstract
Hypoxia-adapted cancer cells in tumors contribute to the pathological progression of cancer. The marine spongean sesquiterpene phenols dictyoceratin-A (1) and -C (2) have been shown to induce hypoxia-selective growth inhibition in cultured cancer cells and exhibit in vivo antitumor effects. These compounds inhibit the accumulation of hypoxia-inducible factor-1α (HIF-1α), which is a drug target in hypoxia-adapted cancer cells, under hypoxic conditions. However, the target molecules of compounds 1 and 2, which are responsible for decreasing HIF-1α expression under hypoxic conditions, remain unclear. In this study, we synthesized probe molecules for compounds 1 and 2 to identify their target molecules and found that both compounds bind to RNA polymerase II-associated protein 3 (RPAP3), which is a component of the R2TP/Prefoldin-like (PEDL) complex. In addition, RPAP3-knockdown cells showed a phenotype similar to that of compound-treated cells.
AuthorsTakashi Kawachi, Shun Tanaka, Akinori Fukuda, Yuji Sumii, Andi Setiawan, Naoyuki Kotoku, Motomasa Kobayashi, Masayoshi Arai
JournalMarine drugs (Mar Drugs) Vol. 17 Issue 3 (Mar 08 2019) ISSN: 1660-3397 [Electronic] Switzerland
PMID30857246 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Apoptosis Regulatory Proteins
  • Biological Products
  • Carrier Proteins
  • Hydroxybenzoates
  • RNA, Small Interfering
  • RPAP3 protein, human
  • Sesquiterpenes
  • dictyoceratin-C
  • smenospondiol
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Apoptosis Regulatory Proteins
  • Biological Products (pharmacology)
  • Carrier Proteins (antagonists & inhibitors, genetics, metabolism)
  • Cell Hypoxia (drug effects)
  • Cell Line, Tumor
  • Gene Knockdown Techniques
  • Humans
  • Hydroxybenzoates (pharmacology)
  • Molecular Targeted Therapy (methods)
  • Neoplasms (drug therapy, pathology)
  • Porifera
  • RNA, Small Interfering (metabolism)
  • Sesquiterpenes (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: